phenylalanine and Sicca Syndrome

phenylalanine has been researched along with Sicca Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asbell, PA; Kuklinski, E	1
Contreras-Ruiz, L; Krauss, AH; Masli, S; Mir, FA; Turpie, B	1
Apinhasmit, W; Baum, BJ; Birkedal-Hansen, H; Chen, ZJ; Lafrenie, RM; Park, C; Stetler-Stevenson, WG; Wu, AJ; Yamada, KM	1

Reviews

1 review(s) available for phenylalanine and Sicca Syndrome

Article	Year
Sjogren's syndrome from the perspective of ophthalmology. Clinical immunology (Orlando, Fla.), 2017, Volume: 182 Topics: Administration, Ophthalmic; Cyclosporine; Dry Eye Syndromes; Fatty Acids, Omega-3; Glucocorticoids; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Muscarinic Agonists; Ophthalmology; Phenylalanine; Pilocarpine; Punctal Plugs; Quinuclidines; Sjogren's Syndrome; Sulfones; Thiophenes	2017

Article

Year

Sjogren's syndrome from the perspective of ophthalmology.

Clinical immunology (Orlando, Fla.), 2017, Volume: 182

Topics: Administration, Ophthalmic; Cyclosporine; Dry Eye Syndromes; Fatty Acids, Omega-3; Glucocorticoids; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Muscarinic Agonists; Ophthalmology; Phenylalanine; Pilocarpine; Punctal Plugs; Quinuclidines; Sjogren's Syndrome; Sulfones; Thiophenes

2017

Other Studies

2 other study(ies) available for phenylalanine and Sicca Syndrome

Article	Year
Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090. Experimental eye research, 2016, Volume: 143 Topics: Administration, Topical; Animals; Cell Count; Dexamethasone; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Glucocorticoids; Goblet Cells; Integrin alpha4beta1; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Ophthalmic Solutions; Phenylalanine; Piperidines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome; Staining and Labeling; Thrombospondin 1	2016
Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. Journal of cellular physiology, 1997, Volume: 171, Issue:2 Topics: Animals; Antibodies, Monoclonal; Binding, Competitive; Blotting, Northern; Cell Division; Cell Line; Collagenases; Epithelial Cells; Epithelium; Gelatinases; Humans; Interferon-gamma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Parotid Gland; Phenylalanine; Protease Inhibitors; Receptors, Interferon; RNA, Messenger; Saliva; Sjogren's Syndrome; Thiophenes; Tumor Necrosis Factor-alpha	1997

Article

Year

Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.

Experimental eye research, 2016, Volume: 143

Topics: Administration, Topical; Animals; Cell Count; Dexamethasone; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Glucocorticoids; Goblet Cells; Integrin alpha4beta1; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Ophthalmic Solutions; Phenylalanine; Piperidines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome; Staining and Labeling; Thrombospondin 1

2016

Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.

Journal of cellular physiology, 1997, Volume: 171, Issue:2

Topics: Animals; Antibodies, Monoclonal; Binding, Competitive; Blotting, Northern; Cell Division; Cell Line; Collagenases; Epithelial Cells; Epithelium; Gelatinases; Humans; Interferon-gamma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Parotid Gland; Phenylalanine; Protease Inhibitors; Receptors, Interferon; RNA, Messenger; Saliva; Sjogren's Syndrome; Thiophenes; Tumor Necrosis Factor-alpha

1997